6-MAPB
6-MAPB (6-Methylaminopropylbenzofuran) is a synthetic entactogen and stimulant of the benzofuran class. It is structurally related to MDMA and 6-APB, and it is known for its psychoactive effects.
Chemical Structure and Properties[edit]
6-MAPB is a benzofuran derivative, which means it contains a benzene ring fused to a furan ring. The chemical structure of 6-MAPB is similar to that of MDMA (3,4-methylenedioxy-N-methylamphetamine), but with a benzofuran ring replacing the methylenedioxy ring. The molecular formula of 6-MAPB is C12H15NO, and its molecular weight is 189.25 g/mol.
Pharmacology[edit]
6-MAPB acts primarily as a releasing agent of serotonin, dopamine, and norepinephrine. This action is similar to that of MDMA, which is known for its ability to induce feelings of euphoria, increased sociability, and empathy. The exact mechanism of action of 6-MAPB is not fully understood, but it is believed to increase the levels of these neurotransmitters in the brain by inhibiting their reuptake and promoting their release.
Effects[edit]
The effects of 6-MAPB are reported to be similar to those of MDMA and 6-APB. Users have described feelings of euphoria, increased energy, enhanced sensory perception, and emotional closeness. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with the peak effects lasting for 3 to 4 hours. The total duration of effects can last up to 6 to 8 hours.
Legal Status[edit]
The legal status of 6-MAPB varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it may be legal or unregulated. It is important to check the specific laws in your country or region regarding the possession, use, and distribution of 6-MAPB.
Safety and Risks[edit]
As with other psychoactive substances, the use of 6-MAPB carries potential risks. These can include adverse physical and psychological effects, such as increased heart rate, hypertension, anxiety, and paranoia. There is also the potential for neurotoxicity and other long-term health effects, although the extent of these risks is not well-documented due to the limited research on 6-MAPB.
Related Compounds[edit]
See Also[edit]
References[edit]
External Links[edit]
